Skip to main content
Premium Trial:

Request an Annual Quote

Venter Center, University of Washington, Johns Hopkins to Conduct Resequencing Study for NHLBI Program

NEW YORK, Feb. 6 (GenomeWeb News) - The J. Craig Venter Institute said today that it is conducting resequencing and genotyping research with the University of Washington, Seattle, and Johns Hopkins University on five projects selected by the National Institutes of Health's National Heart, Lung, and Blood Institute.


The work is part of the NHLBI's Resequencing and Genotyping Service, which was established to enable researchers to more rapidly identify disease pathways of heart, lung, and blood diseases, as well as sleep disorders, ultimately enabling discovery of targeted therapeutics.


According to the Venter Institute, the researchers will resequence genes and genetic regions using a PCR-based strategy for the amplification of genomic DNA, followed by capillary-based dye-terminator sequencing.


Johns Hopkins is performing genotyping analysis primarily through the use of its high-throughput Illumina BeadLab system within the Genetic Resources Core Facility of the McKusick-Nathans Institute of Genetic Medicine.

The Scan

Guidelines for Ancient DNA Work

More than two dozen researchers have developed new ethical guidelines for conducting ancient DNA research, which they present in Nature.

And Cleared

A UK regulator has cleared former UK Prime Minister David Cameron in concerns he should have registered as a consultant-lobbyist for his work with Illumina, according to the Financial Times.

Suit Over Allegations

The Boston Globe reports that David Sabatini, who was placed on leave from MIT after allegations of sexual harassment, is suing his accuser, the Whitehead Institute, and the institute's director.

Nature Papers on Esophageal Cancer, Origin of Modern Horses, Exome Sequencing of UK Biobank Participants

In Nature this week: genetic and environmental influences of esophageal cancer, domestic horse origin traced to Western Eurasian steppes, and more.